Navigation Links
AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing
Date:11/19/2009

hold. This is exactly what we did with our Alzheimer's vaccination program and the outcome in the Phase I trials at this stage enabled us to make this decision earlier than we expected and to offer a booster vaccination to the AD02-treated patients. Finally, we can also redirect our resources which will now be available for our other vaccination programs." AFFiRiS AG can also invest all of the EUR 10 million, paid by licensing partner GSK Biologicals as a milestone payment for the positive completion of the Phase I studies, in the other R&D programs.

The vaccine development program of AFFiRiS is based on the company's AFFITOME(R) technology, which also delivered the vaccines tested so far. Also based on this technology are six other vaccination programs being developed by AFFiRiS AG, which target, among other indications, Parkinson's disease and atherosclerosis.

About AFFiRiS AG (status November 2009):

Based on proprietary patent positions, AFFiRiS has developed tailored peptide vaccines against Alzheimer's Disease, Parkinson's and four other diseases characterized by urgent medical requirement and attractive market volumes. Alzheimer's is the current lead indication and clinical Phase I trials have just been completed on two product candidates. AFFiRiS succeeded in attracting GlaxoSmithKline Biologicals as its licensing partner in October 2008. The contract contains provisions for (milestone-dependent) payments of up to EUR 430 million. Based on the successful completion of two clinical Phase I trials, a payment of EUR 10 million was made in October. AFFiRiS currently employs 60 highly-qualified staff at its premises on the St. Marx Campus in Vienna, Austria (http://www.affiris.com).


    Contact AFFiRiS AG:
    Mag. Agnes Meyer
    Karl-Farkas-Gasse 22
    T +43-1-798-15-75-3
    mailto:agnes.meyer@affiris.com
    '/>"/>
SOURCE AFFiRiS AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS
2. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
3. GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimers Disease Candidate Vaccines
4. AFFiRiS - MIG-Fonds Increases Investment by Euro 3 Million
5. Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference
6. Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference
7. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 September 2009
8. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
9. Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
10. Bavarian Nordic A/S - Half Year Interim Report 2009
11. Arpida Reports Interim Results For Six Months to 30 June 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 This is a professional ... China Isopropanol (IPA) industry. The report provides a ... and industry chain structure. Global market analysis and ... focus on history, developments, trends and competitive landscape ... and Chinese situation is also offered. , The ...
(Date:9/23/2014)... 23, 2014 Equashield ( ...     Devices  (CSTD) for hazardous drugs, ... Medical Technology Corporation.  Equashield,s leading CSTD has been ... , China and ... to expand globally, and throughout the ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black Box ( ... three phase process that can lead to the creation ... go far beyond anything previously imagined. First everyone must ... , “Every effort to improve the quality of healthcare ... throughout that system because all of the experts have ...
(Date:9/23/2014)... , September 23, 2014 ... with funding from Imperial Innovations, Cambridge Innovation Capital and ... a clinical cancer genomics company focused on harnessing ... to improve cancer testing and treatment, today announced ... led by Imperial Innovations and including Cambridge Innovation ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4
... two of a three-part series focusing on the past, present and future ... up to WTNs interview with Nettles in March 2003. , ... During the next six to 12 months, what Dept. of Commerce initiatives ... Nettles: I had a meeting with Gov. Doyle a couple of ...
... the effectiveness of your companys next web site is to let ... process of paper prototyping. , ,Paper prototyping is a fast, low-cost ... of a web site design and inviting some of your users ... instead of a mouse, to complete important tasks. , ,As ...
... has emerged as a new leading security solution that ... more holistic and efficient approach to security. It is ... networks. , ,Most security imperatives from an IT perspective ... a host of similar components of network security. But ...
Cached Biology Technology:WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 2WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 3WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 4WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 5How Good Does Your Web Site Look on Paper? 2IP Surveillance - Another Piece of the Converged Network 2IP Surveillance - Another Piece of the Converged Network 3
(Date:9/23/2014)... Research by Rice University scientists who are fighting a ... be a clinician,s most powerful ally. , "Recent research ... cyberwarfare against the immune system, and we studied the ... how we might turn the tables on cancer," said ... this week in the Early Edition of the ...
(Date:9/23/2014)... about whose turn it is to do the washing up, ... noise as many students returning to university for the ... sharing a house can be a tricky business. , And ... revealed that new technology to allow people to monitor their ... up the tension. , The study by a team of ...
(Date:9/23/2014)... 2014 Research and Markets  has announced ... and Opportunities, 2019" report to their offering. ... enhancing security and protection in private as well as ... country,s government is focusing on using biometric systems to ... national IDs that are of crucial importance to the ...
Breaking Biology News(10 mins):Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Smart meters could cause conflict for housemates, study shows 2Smart meters could cause conflict for housemates, study shows 3India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... Blacksburg, Va. -- Virginia Tech College of Engineering researchers ... to study engineered tissues that mimic the liver, one ... Padma Rajagopalan , an assistant professor in ... designing liver mimics that eventually could form the basis ...
... the most significant events in the history of the ... In the late 1800s, Darwin referred to their development ... still challenged by this "mystery" of how angiosperms originated, ... 2009 issue of the American Journal of Botany ...
... proteins underlying the plasma membrane keeps epithelial cells in shape ... say Nowak et al. The study will appear in the ... Biology (online September 14). Spectrin, F-actin, and associated ... membrane of red blood cells. A similar network underlies the ...
Cached Biology News:Engineering team to design and study liver mimics 2Engineering team to design and study liver mimics 3Secrets in a seed: Clues into the evolution of the first flowers 2
Edited by D.M. Gersten (1996) Provides comprehensive descriptions of the techniques available for analytical gel electrophoresis of proteins and offers clear step-by-step protocols for all of the m...
...
All serum is collected from U.S.D.A. fryers and broilers. Pricing: $15/unit for 1 - 10 units; $12/unit for 11 - 50 units...
RAT ANTI MOUSE TCR V BETA 7:RPE Immunogen: T-cell lymphoma TK1...
Biology Products: